Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis.

MLA

Michelsen, Brigitte, et al. “Impact of Discordance between Patient’s and Evaluator’s Global Assessment on Treatment Outcomes in 14 868 Patients with Spondyloarthritis.” Rheumatology (Oxford, England), vol. 59, no. 9, Sept. 2020, pp. 2455–61. EBSCOhost, https://doi.org/10.1093/rheumatology/kez656.

APA

Michelsen, B., Ørnbjerg, L. M., Kvien, T. K., Pavelka, K., Nissen, M. J., Nordström, D., Santos, M. J., Koca, S. S., Askling, J., Rotar, Z., Gudbjornsson, B., Codreanu, C., Loft, A. G., Kristianslund, E. K., Mann, H. F., Ciurea, A., Eklund, K. K., Vieira-Sousa, E., Yazici, A., … Østergaard, M. (2020). Impact of discordance between patient’s and evaluator’s global assessment on treatment outcomes in 14 868 patients with spondyloarthritis. Rheumatology (Oxford, England), 59(9), 2455–2461. https://doi.org/10.1093/rheumatology/kez656

Chicago

Michelsen, Brigitte, Lykke Midtbøll Ørnbjerg, Tore K Kvien, Karel Pavelka, Michael J Nissen, Dan Nordström, Maria José Santos, et al. 2020. “Impact of Discordance between Patient’s and Evaluator’s Global Assessment on Treatment Outcomes in 14 868 Patients with Spondyloarthritis.” Rheumatology (Oxford, England) 59 (9): 2455–61. doi:10.1093/rheumatology/kez656.